These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23265905)
1. Design and synthesis of novel 2-methyl-4,5-substitutedbenzo[f]-3,3a,4,5-tetrahydro-pyrazolo[1,5-d][1,4]oxazepin-8(7H)-one derivatives as telomerase inhibitors. Liu XH; Jia YM; Song BA; Pang ZX; Yang S Bioorg Med Chem Lett; 2013 Feb; 23(3):720-3. PubMed ID: 23265905 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents. Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors. Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents. Liu XH; Li J; Shi JB; Song BA; Qi XB Eur J Med Chem; 2012 May; 51():294-9. PubMed ID: 22405648 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents. Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology. Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors. Luo Y; Zhang S; Qiu KM; Liu ZJ; Yang YS; Fu J; Zhong WQ; Zhu HL Bioorg Med Chem Lett; 2013 Feb; 23(4):1091-5. PubMed ID: 23312949 [TBL] [Abstract][Full Text] [Related]
8. Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo. Shi JB; Chen LZ; Wang Y; Xiou C; Tang WJ; Zhou HP; Liu XH; Yao QZ Eur J Med Chem; 2016 Nov; 124():729-739. PubMed ID: 27639364 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent. Sun J; Zhu H; Yang ZM; Zhu HL Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864 [TBL] [Abstract][Full Text] [Related]
11. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity. Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives. Lee CC; Huang KF; Lin PY; Huang FC; Chen CL; Chen TC; Guh JH; Lin JJ; Huang HS Eur J Med Chem; 2012 Jan; 47(1):323-36. PubMed ID: 22100139 [TBL] [Abstract][Full Text] [Related]
13. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. Wang Y; Cheng FX; Yuan XL; Tang WJ; Shi JB; Liao CZ; Liu XH Eur J Med Chem; 2016 Apr; 112():231-251. PubMed ID: 26900656 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents. Liu XH; Liu HF; Chen J; Yang Y; Song BA; Bai LS; Liu JX; Zhu HL; Qi XB Bioorg Med Chem Lett; 2010 Oct; 20(19):5705-8. PubMed ID: 20800480 [TBL] [Abstract][Full Text] [Related]
15. 3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective lead. Soth M; Abbot S; Abubakari A; Arora N; Arzeno H; Billedeau R; Dewdney N; Durkin K; Frauchiger S; Ghate M; Goldstein DM; Hill RJ; Kuglstatter A; Li F; Loe B; McCaleb K; McIntosh J; Papp E; Park J; Stahl M; Sung ML; Suttman R; Swinney DC; Weller P; Wong B; Zecic H; Gabriel T Bioorg Med Chem Lett; 2011 Jun; 21(11):3452-6. PubMed ID: 21515047 [TBL] [Abstract][Full Text] [Related]
16. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects. Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149 [TBL] [Abstract][Full Text] [Related]
17. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. Perry PJ; Read MA; Davies RT; Gowan SM; Reszka AP; Wood AA; Kelland LR; Neidle S J Med Chem; 1999 Jul; 42(14):2679-84. PubMed ID: 10411488 [TBL] [Abstract][Full Text] [Related]
18. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro. Chen X; Zha GF; Wang JQ; Liu XH J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286 [TBL] [Abstract][Full Text] [Related]
19. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone. Huang HS; Chiou JF; Fong Y; Hou CC; Lu YC; Wang JY; Shih JW; Pan YR; Lin JJ J Med Chem; 2003 Jul; 46(15):3300-7. PubMed ID: 12852760 [TBL] [Abstract][Full Text] [Related]
20. Discovery and synthesis of a novel series of potent, selective inhibitors of the PI3Kα: 2-alkyl-chromeno[4,3-c]pyrazol-4(2H)-one derivatives. Yin Y; Wu X; Han HW; Sha S; Wang SF; Qiao F; Lu AM; Lv PC; Zhu HL Org Biomol Chem; 2014 Dec; 12(45):9157-65. PubMed ID: 25296388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]